ZYME Q3 2023 Earnings — Zymeworks Inc. Revenue & Financial Results | Market Cap Arena

ZYMEZymeworks Inc.

$2B

Q3 2023 Earnings

Healthcare Biotechnology

Income Statement

Revenue

$17M+527.4% YoY

Gross Profit

$17M100.0% margin

Operating Income

-$33M-201.4% margin

Net Income

-$29M-173.8% margin

EPS (Diluted)

$-0.41

QoQ Revenue Growth

+135.7%

Cash Flow

Operating Cash Flow

-$43M

Free Cash Flow

-$44M

Stock-Based Comp.

$2M

Balance Sheet

Total Assets

$556M

Total Liabilities

$132M

Stockholders' Equity

$424M

Cash & Equivalents

$94M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$17M	$3M	+527.4%
Gross Profit	$17M	-$34M	+147.9%
Operating Income	-$33M	-$50M	+34.0%
Net Income	-$29M	-$48M	+40.0%

Revenue Segments

Research Support Payments And Other Service

$10M100%